Purchase by Donald Olds of 381 shares of Acasti Pharma
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Slightly above 62% of ACST Old's investor base is looking to short. The analysis of current outlook of investing in ACST Old suggests that many traders are alarmed regarding ACST Old's prospects. ACST Old's investing sentiment can be driven by a variety of factors including economic data, ACST Old's earnings reports, geopolitical events, and overall market trends.
ACST |
Filed transaction by Acasti Pharma Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
ACST Old Fundamental Analysis
We analyze ACST Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACST Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACST Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
ACST Old is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
ACST Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACST Old stock to make a market-neutral strategy. Peer analysis of ACST Old could also be used in its relative valuation, which is a method of valuing ACST Old by comparing valuation metrics with similar companies.
Peers
ACST Old Related Equities
| TNXP | Tonix Pharmaceuticals | 33.33 | ||||
| IBIO | Ibio | 5.14 | ||||
| BPTH | Bio Path | 3.57 | ||||
| PULM | Pulmatrix | 2.17 | ||||
| OCGN | Ocugen | 1.33 | ||||
| JAGX | Jaguar Animal | 1.19 | ||||
| ABVC | ABVC Biopharma | 1.82 | ||||
| AKTX | Akari Therapeutics | 2.33 | ||||
| MBRX | Moleculin Biotech | 2.78 | ||||
| GOVX | GeoVax Labs | 4.95 | ||||
| ADTX | Aditxt | 8.33 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in ACST Stock
If you are still planning to invest in ACST Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACST Old's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |